157 related articles for article (PubMed ID: 24132401)
21. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jochmans K; Mullier F; Wijns W; Soumali MR; Coucke W; Vernelen K; Van de Walle P
Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
[TBL] [Abstract][Full Text] [Related]
22. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
Tschaikowsky K; Balint R; Pscheidl E; Bremer F
Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
[TBL] [Abstract][Full Text] [Related]
23. Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT).
Kaptanoglu AF; Uncu M; Ozyurt S; Hincal E
J Dermatolog Treat; 2013 Aug; 24(4):272-4. PubMed ID: 22188511
[TBL] [Abstract][Full Text] [Related]
24. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
25. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
26. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery.
Meesters MI; Vonk AB; van de Weerdt EK; Kamminga S; Boer C
Thromb Res; 2014 Jun; 133(6):1141-4. PubMed ID: 24703296
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure.
Torres A; Rubinstein E; Corey GR; Stryjewski ME; Barriere SL
J Antimicrob Chemother; 2014 Apr; 69(4):1119-26. PubMed ID: 24398339
[TBL] [Abstract][Full Text] [Related]
28. A cartridge based sensor array platform for multiple coagulation measurements from plasma.
Cakmak O; Ermek E; Kilinc N; Bulut S; Baris I; Kavakli IH; Yaralioglu GG; Urey H
Lab Chip; 2015 Jan; 15(1):113-20. PubMed ID: 25353144
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time.
Kitchen S; Geisen U; Kappelmayer J; Quehenberger P; Drieß J; Lowe A; Jones R; Boehm JG; Miles G; Rozsnyai G
Int J Lab Hematol; 2018 Dec; 40(6):645-654. PubMed ID: 30033570
[TBL] [Abstract][Full Text] [Related]
30. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity and specificity of 20-minute whole blood clotting test, prothrombin time, activated partial thromboplastin time tests in diagnosis of defibrination following Malayan pit viper envenoming.
Thongtonyong N; Chinthammitr Y
Toxicon; 2020 Oct; 185():188-192. PubMed ID: 32712023
[TBL] [Abstract][Full Text] [Related]
33. Comparison of international normalized ratio measurement between CoaguChek XS Plus and STA-R coagulation analyzers.
Hur M; Kim H; Park CM; La Gioia A; Choi SG; Choi JH; Moon HW; Yun YM
Biomed Res Int; 2013; 2013():213109. PubMed ID: 23509691
[TBL] [Abstract][Full Text] [Related]
34. Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite(R) during acute haemorrhage.
Gauss T; Hamada S; Jurcisin I; Dahmani S; Boudaoud L; Mantz J; Paugam-Burtz C
Br J Anaesth; 2014 Mar; 112(3):514-20. PubMed ID: 24335551
[TBL] [Abstract][Full Text] [Related]
35. Point-of-care (POC) measurement of coagulation after cardiac surgery.
Boldt J; Walz G; Triem J; Suttner S; Kumle B
Intensive Care Med; 1998 Nov; 24(11):1187-93. PubMed ID: 9876982
[TBL] [Abstract][Full Text] [Related]
36. Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools.
van den Besselaar AMHP; Abdoel CF; van Rijn CJJ; van der Meer FJM; Cobbaert CM
Clin Chem Lab Med; 2019 Aug; 57(9):1349-1357. PubMed ID: 30763258
[TBL] [Abstract][Full Text] [Related]
37. Analytical performance evaluation of Sysmex CS-2500 and Stago STA Compact.
Yis OM; Bugdayci G; Pehlivan MB; Yildiz RN; Alisik M
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):324-329. PubMed ID: 32398465
[TBL] [Abstract][Full Text] [Related]
38. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels.
Francart SJ; Hawes EM; Deal AM; Adcock DM; Gosselin R; Jeanneret C; Friedman KD; Moll S
Thromb Haemost; 2014 Jun; 111(6):1133-40. PubMed ID: 24401946
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.
De Luca R; Fontana P; Poncet A; de Moerloose P; Pfister RE
Thromb Res; 2014 Aug; 134(2):474-8. PubMed ID: 24951336
[TBL] [Abstract][Full Text] [Related]
40. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
